North American Management’s Biogen BIIB Stock Holding History

North American Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-650	Closed	-$206K	–	107
2020 Q1	$206K	Buy	+650	New	+$197K	0.04%	104
2019 Q1	–	Sell	-710	Closed	-$214K	–	123
2018 Q4	$214K	Hold	710	–	–	0.04%	113
2018 Q3	$251K	Sell	710 -15	-2%	-$5.16K	0.04%	119
2018 Q2	$210K	Buy	+725	New	+$204K	0.03%	124
2018 Q1	–	Sell	-725	Closed	-$231K	–	130
2017 Q4	$231K	Hold	725	–	–	0.04%	122
2017 Q3	$227K	Sell	725 -26	-3%	-$7.7K	0.04%	119
2017 Q2	$204K	Hold	751	–	–	0.03%	129
2017 Q1	$205K	Buy	751 +26	+4%	+$7.35K	0.03%	126
2016 Q4	$206K	Sell	725 -10	-1%	-$2.96K	0.03%	126
2016 Q3	$230K	Buy	+735	New	+$218K	0.04%	126
2016 Q1	–	Sell	-735	Closed	-$225K	–	143
2015 Q4	$225K	Buy	+735	New	+$211K	0.04%	139

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

North American Management's BIIB Position: Q2 2020 in Review

North American Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 650 shares — an estimated $206K sold.

North American Management first reported a position in BIIB in Q4 2015 and held it in 11 quarters. The position peaked at $251K in Q3 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

North American Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
North American Management sold 650 Biogen shares in Q2 2020, an estimated $206K.
North American Management first reported a position in Biogen in Q4 2015 and held it in 11 quarters.
North American Management's Biogen position peaked at $251K in Q3 2018.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on North American Management's 13F filing for Q2 2020, filed 3 Aug 2020.